Idiopathic Pulmonary Fibrosis Current Events | Idiopathic Pulmonary Fibrosis News | 3
|
| Page
3 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
Breathe deep: Which patients could benefit from inhaled steroids in cystic fibrosis?
A specific variation in the glucocorticoid receptor gene is associated with lung disease progression in cystic fibrosis, research published this week in the online open access journal Respiratory Research reveals. view more (2007-11-29)
Abnormal immune cells may cause unprovoked anaphylaxis
Two new clinical reports shed light on why some people suffer from recurrent episodes of idiopathic anaphylaxis--a potentially life-threatening condition of unknown cause characterized by a drop in blood pressure, fainting episodes, difficulty in breathing, and wheezing. view more (2007-11-12)
UCSF marks a milestone with 500th transplant in heart and lung program
UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung. view more (2008-04-25)
Scientists discover basic defect in cystic fibrosis airway glands
Scientists at Stanford University have determined that the buildup of sticky mucus found in cystic fibrosis is caused by a loss in the epithelial cell's ability to secrete fluid. view more (2006-03-20)
Trial Reveals Safer And Simpler Approach To Treating Children With Cystic Fibrosis
Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET. view more (2005-02-09)
Protein opens hope of treatment for cystic fibrosis patients
Scientists have finally identified a direct role for the missing protein that leaves cystic fibrosis patients open to attack from lung-damaging bacteria, the main reason most of them die before their 35th birthday, scientists heard today (Thursday 11 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at... view more... (2008-09-11)
Study provides guidelines for treatment of juvenile idiopathic arthritis
A study published by the Cleveland Clinic and The Hospital for Sick Children (SickKids) provides the medical community for the first time with specific guidelines for treating juvenile idiopathic arthritis (JIA), previously known as juvenile rheumatoid arthritis (JRA), a condition that affects approximately one in every 1,000 children. view more (2005-10-05)
Key Found to Kill Cystic Fibrosis Superbug
Researchers from the Schulich School of Medicine & Dentistry at The University of Western Ontario , working with a group from Edinburgh, have discovered a way to kill the cystic fibrosis superbug, Burkholderia cenocepacia. view more (2007-04-25)
Study reveals how cells destroy faulty proteins in cystic fibrosis
The cellular system that degrades faulty proteins created by the cystic fibrosis gene has been identified by University of North Carolina at Chapel Hill scientists. view more (2006-08-11)
Cystic fibrosis treatments may have unseen long-term benefits
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests. view more (2009-07-17)
Melatonin may be served as a potential anti-fibrotic drug
In China, the incidence of liver cirrhosis is still high. Liver cirrhosis results from fibrosis. If treated properly at fibrosis stage, cirrhosis can be prevented. view more (2009-03-31)
Scientists find gene that modifies severity of cystic fibrosis lung disease
Researchers at Wake Forest University Baptist Medical Center, and colleagues, have identified a gene that modifies the severity of lung disease in people with cystic fibrosis, a lethal genetic condition. The findings open the door to possible new targets for treatment, researchers say. view more (2009-03-04)
Research examines variations of rare lung disease
Lymphangioleiomyomatosis, or LAM, is a rare but serious lung disease that may cause severe respiratory symptoms in patients. The often-fatal disease has no cure. view more (2008-08-27)
Atrial fibrillation in endurance athletes still poses problems for sports cardiologists
The fulfilment which so many people increasingly derive from competitive sports and endurance training comes with a real - even if rare - twist. view more (2009-06-22)
Research promising for cystic fibrosis
New U of T research holds promise for developing innovative therapies against cystic fibrosis and may also serve as a model for future therapies against the HIV virus. view more (2008-03-19)
UT Southwestern researchers identify gene linked to inherited form of fatal lung disease
Researchers at UT Southwestern Medical Center have determined that a mutation in a gene known for its role in defending the lungs against invading pathogens is responsible for some inherited cases of a lethal lung disease affecting older adults. The same mutation may also be associated with lung cancer, the researchers said. view more (2008-12-22)
University of Ulster Innovation Aids Cystic Fibrosis Patients Worldwide
A new exercise technique developed by a University of Ulster physiotherapist is helping cystic fibrosis (CF) sufferers worldwide. The new exercise measuring technique, pioneered by Dr Judy Bradley, a lecturer/practitioner in physiotherapy at the University' of Ulster, is to be discussed by Europe's top clinicians and researchers at a conference... view more... (2003-05-23)
Type of stem cell found to reside in transplanted lungs
A new study involving a type of stem cells from the lungs of transplant patients demonstrates for the first time that these progenitor cells reside in adult organs and are not derived from bone marrow, which leads to the possibility that the cells may be able to help with the rejection of donated organs and with various kinds of lung disease. view more (2007-03-09)
Proteins may predict lung transplant rejection
Using the latest in high tech tools, researchers have identified three proteins that were highly predictive of chronic lung rejection up to 20 months before the rejection occurred. view more (2006-11-03)
First report of cancer drug Gleevec as new target therapy for pulmonary hypertension
Gleevec (Imatinib) is a representative of the newest generation of cancer drugs. The substance conveys its potent anti-proliferative effect by selectively supressing the tyrosine kinase pathway. view more (2005-09-30)
|
|
| Page
3 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
|
